$5.850
-0.010 (-0.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GYRE Prediction & Forecast by Similar Chart Analysis
Alphio's GYRE stock price prediction model matches the current Gyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.81 (-0.67%). The 1-week path is $5.86 (+0.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Gyre Therapeutics Inc Stock?
Gyre Therapeutics is not a good buy right now due to significant financial losses and poor technical indicators. The current price is $5.85, and the RSI is extremely low at 18.31, indicating oversold conditions but also potential for further declines. The company's net loss for Q2 2026 was $11.66 million, a 472% increase from the previous year, which raises concerns about profitability and future growth.
GYRE stock price ended at $5.85 on Friday, after losing -0.17%
Gyre Therapeutics Inc (GYRE) last closed at $5.85, losing -0.17%. These facts feed the 1-day and 1-week GYRE price prediction above.
Forecast Drivers
Gyre Therapeutics Inc (GYRE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GYRE, ranked by similarity.
Seasonality analysis for GYRE
Historically the probability of a positive October return for GYRE is 11.11%. February offers the highest probability of a positive month at 46.55%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.